Ricerca Biosciences Announces Strategic Collaboration Agreement with Fulcrum Pharma Developments Ltd., an Aptiv Corporation

Published: Mar 03, 2011

CONCORD, Ohio--(BUSINESS WIRE)--Ricerca Biosciences, an integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, is pleased to announce a strategic partnership with Fulcrum Pharma, an Aptiv Solutions company, a leading provider of drug development consulting and regulatory services essential to progress a development program from research to product approval. The collaboration provides unique, value-added capabilities to biopharmaceutical companies by creating a streamlined and efficient process to move a candidate from development to clinical evaluation.

Back to news